Hydrocodone Bitartate And Acetaminophen
Product Images NDC 76519-1011

3 FDA label images from H.j. Harkins Company, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Hydrocodone Bitartate And Acetaminophen (NDC 76519-1011). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by H.j. Harkins Company, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

76519 1011 Ppac Label

76519 1011 Ppac Label
Label for Hydrocodone Bitartate and Acetaminophen 2.5/325 mg tablets from H.J. Harkins Company, Inc. The label shows the NDC 76519-1011-XX and includes a caution statement about federal law restricting drug transfer. It displays lot number AB00CD, an expiration date placeholder, barcode marks, and a prescription instruction to use as directed by a physician. Small individual label sections repeat key product details with the manufacturer listed as Actavis.*
FDA Label Image

Image 1

Image 1
Chemical structure diagram showing the molecular formula C8H9NO2 and molecular weight 151.17, representing the active ingredient acetaminophen in Hydrocodone Bitartate and Acetaminophen.*
FDA Label Image

Image

Image
Chemical structure of Hydrocodone Bitartate and Acetaminophen hydrate complex showing molecular formulas and molecular weight (494.49 Da). The diagram includes the chemical structure of hydrocodone, bitartaric acid, acetaminophen moieties, and hydration elements.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.